Latest Regulatory Approvals News

Buru Energy is progressing steadily on its Rafael Project, aiming for commercial agreements in early 2025 and production by late 2027, while implementing significant cost reductions to sharpen its financial position.

Recce Pharmaceuticals has successfully dosed all patients in its Phase II trial of RECCE® 327 topical gel for acute bacterial skin infections, showing encouraging preliminary efficacy and safety data. The company is preparing for pivotal Phase III trials in Australia and Indonesia, targeting a significant global market opportunity.

New Frontier Minerals has entered a strategic alliance with Austral Resources to process copper ore from its Big One Deposit, aiming to accelerate production and exploration in the Mt Isa copper belt.

Iron Road Ltd has secured a $3 million milestone payment from Amp Energy and made significant progress on its Cape Hardy Industrial Port Precinct and Central Eyre Iron Project slurry pipeline study, reinforcing its strong cash position and strategic development plans.

iTech Minerals has entered a binding agreement with global lithium giant SQM to jointly develop the Reynolds Range Lithium Project, marking a significant step forward for the Northern Territory asset. This partnership enables SQM to earn up to a 70% stake in lithium rights, backed by a structured investment and exploration program.

Golden State Mining's December Quarterly Report reveals promising exploration progress with three new gold target areas identified near the 11.2Moz Hemi deposit, alongside encouraging assay results from Canning Hill and planned drilling at Southern Cross East.

Nico Resources Limited reports steady progress on its flagship Wingellina nickel-cobalt project, highlighted by successful metallurgical testwork and Major Project Status recognition, despite cautious spending amid weak market conditions.

Boab Metals has locked in a US$30 million prepayment facility with Trafigura for its Sorby Hills Lead-Silver-Zinc Project and received key environmental approvals, setting the stage for a final investment decision in the second half of 2025.

Korvest Ltd has announced a fully franked ordinary dividend of AUD 0.25 per share for the six months ending December 2024, signaling steady shareholder returns.

Memphasys Limited has secured a major scientific endorsement for its RoXsta™ antioxidant profiling system, positioning the technology for expanded clinical and agricultural applications.

Dimerix has reached a key milestone by enrolling the first paediatric patient aged 12-17 in its ACTION3 Phase 3 trial for DMX-200, advancing its potential treatment for childhood FSGS kidney disease.

Rio Tinto's Q4 2024 production results reflect steady operational performance with record bauxite output and significant progress on key growth projects like Oyu Tolgoi and Rincon lithium expansion.